Citigroup Reiterates Neutral Rating, $100 PT on Edwards Lifesciences Corp.
Posted on February 04, 2013 at 09:55 AM EST
In a report published Monday, Citigroup reiterated its Neutral rating and $100.00 price target on Edwards Lifesciences Corp. (NYSE: EW ). Citigroup noted, “On Friday (2/1), STJ hosted its 2013 Investor Meeting in NYC and discussed its transcatheter and surgical valve products. STJ is the #3 player in tissue valves